Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T82795 | Target Info | |||
Target Name | Beta-catenin (CTNNB1) | ||||
Synonyms | Wnt/beta-catenin signaling pathway; PRO2286; OK/SW-cl.35; Catenin beta-1; CTNNB | ||||
Target Type | Successful Target | ||||
Gene Name | CTNNB1 | ||||
Biochemical Class | Beta-catenin | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acid anhydride hydrolases | [+] 7 Acid anhydride hydrolases | + | |||
Interacting Protein Name | RuvB-like 1 (RUVBL1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ECP54; INO80H; NMP238; PONTIN; Pontin52; RVB1; TIH1; TIP49; TIP49A | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-MS | [3] | |||
4 | Affinity Capture-Western | [4] | |||
5 | Reconstituted Complex | [4] | |||
Interacting Protein Name | Chromodomain-helicase-DNA-binding protein 8 (CHD8) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AUTS18; HELSNF1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [5] | |||
2 | Affinity Capture-Western | [6] | |||
3 | Reconstituted Complex | [5] | |||
4 | Reconstituted Complex | [6] | |||
Interacting Protein Name | Sucrose nonfermenting protein 2 homolog (SMARCA5) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ISWI; SNF2H; WCRF135; hISWI; hSNF2H | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-MS | [3] | |||
4 | Reconstituted Complex | [1] | |||
Interacting Target Name | ATP-dependent RNA helicase DDX5 (DDX5) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RNA helicase p68; Probable ATP-dependent RNA helicase DDX5; HLR1; HELR; G17P1; DEAD box protein 5 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [3] | |||
3 | Affinity Capture-Western | [7] | |||
Interacting Protein Name | RuvB-like 2 (RUVBL2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ECP51; INO80J; REPTIN; RVB2; TIH2; TIP48; TIP49B | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [8] | |||
3 | Co-localization | [8] | |||
Interacting Protein Name | ATP-dependent RNA helicase DDX1 (DDX1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DBP.RB; UKVH5d | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [3] | |||
Interacting Protein Name | ATP-dependent RNA helicase A (DHX9) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DDX9; LKP; NDH2; NDHII; RHA | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [3] | |||
Acyltransferases | [+] 5 Acyltransferases | + | |||
Interacting Target Name | Histone acetyltransferase p300 (EP300) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein propionyltransferase p300; p300 HAT; P300; Histone crotonyltransferase p300; Histone butyryltransferase p300; E1A-associated protein p300; E1Aassociated protein p300 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [9] | |||
2 | Affinity Capture-Western | [9] | |||
3 | Biochemical Activity | [10] | |||
4 | Reconstituted Complex | [9] | |||
Interacting Target Name | Signal transduction protein CBL (CBL) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RNF55; RING-type E3 ubiquitin transferase CBL; RING finger protein 55; Proto-oncogene c-CBL; E3 ubiquitin-protein ligase CBL; C-Cbl; CBL2; Casitas B-lineage lymphoma proto-oncogene | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [11] | |||
2 | Biochemical Activity | [11] | |||
Interacting Protein Name | E3 ubiquitin-protein ligase HUWE1 (HUWE1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ARF.BP1; HECTH9; HSPC272; Ib772; LASU1; MULE; URE.B1; UREB1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [12] | |||
Interacting Protein Name | Histone acetyltransferase KAT2A (KAT2A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | GCN5; GCN5L2; PCAF.b; hGCN5 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [13] | |||
2 | Reconstituted Complex | [1] | |||
Interacting Protein Name | E3 SUMO-protein ligase RanBP2 (RANBP2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ADANE; ANE1; IIAE3; NUP358; TRP1; TRP2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [14] | |||
Auxiliary transporters | [+] 1 Auxiliary transporters | + | |||
Interacting Protein Name | 14-3-3 protein zeta/delta (YWHAZ) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | 14.3.3.zeta; HEL.S.3; HEL4; KCIP.1; YWHAD | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [15] | |||
2 | Affinity Capture-MS | [3] | |||
3 | Affinity Capture-Western | [16] | |||
4 | Affinity Capture-Western | [15] | |||
Carbon-nitrogen hydrolases | [+] 2 Carbon-nitrogen hydrolases | + | |||
Interacting Target Name | Histone deacetylase 1 (HDAC1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RPD3L1; HD1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [17] | |||
3 | Affinity Capture-Western | [18] | |||
4 | Affinity Capture-Western | [19] | |||
Interacting Target Name | Histone deacetylase 7 (HDAC7) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Histone deacetylase 7A; HDAC7A; HD7a; HD7 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [20] | |||
3 | Affinity Capture-Western | [21] | |||
4 | Co-localization | [20] | |||
Ester hydrolases | [+] 1 Ester hydrolases | + | |||
Interacting Protein Name | Histidine triad nucleotide-binding protein 1 (HINT1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HINT; NMAN; PKCI.1; PRKCNH1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [22] | |||
2 | Yeast two hybrid | [23] | |||
Heat shock proteins | [+] 2 Heat shock proteins | + | |||
Interacting Target Name | Heat shock protein 90 beta (HSP90B) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HSP84; HSP 84; Heat shock 84 kDa | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [15] | |||
2 | Affinity Capture-MS | [3] | |||
Interacting Target Name | Lipopolysaccharide-associated protein 1 (HSPA8) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | LPS-associated protein 1; LAP-1; HSPA10; HSP73; HSC70; Heat shock protein 73; Heat shock cognate 71 kDa protein; Heat shock 70 kDa protein 8 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [15] | |||
2 | Affinity Capture-MS | [3] | |||
Intermediate filaments | [+] 1 Intermediate filaments | + | |||
Interacting Protein Name | Lamin-B1 (LMNB1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ADLD; LMN; LMN2; LMNB | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [24] | |||
Isomerases | [+] 1 Isomerases | + | |||
Interacting Target Name | DNA topoisomerase II alpha (TOP2A) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TOP2; DNA topoisomerase II, alpha isozyme; DNA topoisomerase 2-alpha; DNA topoisomerase 2alpha | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [3] | |||
3 | Affinity Capture-Western | [7] | |||
Kinases | [+] 9 Kinases | + | |||
Interacting Target Name | Glycogen synthase kinase-3 beta (GSK-3B) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Serine/threonine-protein kinase GSK3B; GSK-3 beta | ||||
Evidence Score (E-score) | 10 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [25] | |||
3 | Affinity Capture-Western | [26] | |||
4 | Affinity Capture-Western | [27] | |||
5 | Affinity Capture-Western | [28] | |||
6 | Affinity Capture-Western | [29] | |||
7 | Affinity Capture-Western | [30] | |||
8 | Affinity Capture-Western | [31] | |||
9 | Biochemical Activity | [32] | |||
10 | Co-localization | [33] | |||
Interacting Target Name | Erbb2 tyrosine kinase receptor (HER2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine kinase-type cell surface receptor HER2; Tyrosine kinase receptor ErbB2; Receptor tyrosine-protein kinase erbB-2; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; P185erbB2; NGL; NEU proto-oncogene; NEU; MLN19; MLN 19; Metastatic lymph node gene 19 protein; HER2/neu; HER2 (erbB2/neu); HER-2; Erb2; Epidermal growth factor receptor 2; C-erbB-2 oncoprotein; C-erbB-2; CD340 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [34] | |||
2 | Co-localization | [34] | |||
3 | Far Western | [35] | |||
4 | Reconstituted Complex | [35] | |||
Interacting Protein Name | Transformation/transcription domain-associated protein (TRRAP) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PAF350/400; PAF400; STAF40; TR.AP; Tra1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-Western | [36] | |||
4 | Reconstituted Complex | [1] | |||
Interacting Target Name | Epidermal growth factor receptor (EGFR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Epidermal growth factor receptor variant III; Proto-oncogene c-ErbB-1 variant III; Receptor tyrosine-protein kinase erbB-1 variant III; EGFR variant III; ERBB variant III; ERBB1 variant III; HER1 variant III | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [37] | |||
2 | Affinity Capture-Western | [34] | |||
3 | Reconstituted Complex | [38] | |||
Interacting Target Name | Fibroblast growth factor receptor 1 (FGFR1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | N-sam; HBGFR; Fms-like tyrosine kinase 2; FLT-2; FLT2; FLG; FGFR-1; FGFBR; c-fgr; CEK; CD331 antigen; CD331; bFGF-R-1; bFGF-R; BFGFR; Basic fibroblast growth factor receptor 1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [39] | |||
2 | Co-localization | [33] | |||
Interacting Target Name | Fyn tyrosine protein kinase (FYN) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein kinase Fyn; Src-like kinase; SLK; Proto-oncogene tyrosine-protein kinase Fyn; Proto-oncogene Syn; Proto-oncogene c-Fyn; Fyn Protooncogene Syn; Fyn p59-Fyn | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [40] | |||
2 | Co-localization | [33] | |||
Interacting Target Name | Glycogen synthase kinase-3 alpha (GSK-3A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Serine/threonine-protein kinase GSK3A; Serine/threonineprotein kinase GSK3A; GSK-3 alpha; GSK3 alpha; GSK-3; Glycogen synthase kinase3 alpha; Glycogen synthase kinase 3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [41] | |||
2 | Biochemical Activity | [42] | |||
Interacting Target Name | Pyruvate kinase M2 (PKM) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor M2-PK; Thyroid hormone-binding protein 1; THBP1; Pyruvate kinase PKM; Pyruvate kinase muscle isozyme; Pyruvate kinase isozymes M1/M2; Pyruvate kinase 2/3; PKM2; PK3; PK2; p58; Opa-interacting protein 3; OIP-3; OIP3; Cytosolic thyroid hormone-binding protein; CTHBP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Reconstituted Complex | [43] | |||
Interacting Target Name | Large tumor suppressor homolog 2 (LATS2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Warts-like kinase; Serine/threonine-protein kinase LATS2; Serine/threonine-protein kinase kpm; KPM; Kinase phosphorylated during mitosis protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [44] | |||
2 | Proximity Label-MS | [45] | |||
Nuclear hormone receptors | [+] 3 Nuclear hormone receptors | + | |||
Interacting Target Name | Androgen receptor (AR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Testosterone receptor; Nuclear receptor subfamily 3 group C member 4; NR3C4; Dihydrotestosterone receptor; DHTR; Androgen receptor | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [46] | |||
2 | Affinity Capture-Western | [47] | |||
3 | Reconstituted Complex | [48] | |||
4 | Reconstituted Complex | [46] | |||
5 | Reconstituted Complex | [10] | |||
6 | Yeast two hybrid | [48] | |||
Interacting Target Name | Retinoic acid receptor RXR-alpha (RXRA) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RXRalpha; Retinoid X receptor alpha; Nuclear receptor subfamily 2 group B member 1; NR2B1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [49] | |||
3 | Co-localization | [33] | |||
Interacting Target Name | Hepatocyte nuclear factor 4-alpha (HNF4A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor HNF-4; Transcription factor 14; TCF-14; TCF14; Nuclear receptor subfamily 2 group A member 1; NR2A1; HNF-4-alpha; HNF4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [46] | |||
2 | Co-localization | [33] | |||
One-carbon transferases | [+] 2 One-carbon transferases | + | |||
Interacting Target Name | Mixed-lineage leukemia protein (MLL) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Zinc finger protein HRX; Trithorax-like protein; Trithoraxlike protein; p320; p180; Myeloid/lymphoid or mixed-lineage leukemia protein 1; Myeloid/lymphoid or mixed-lineage leukemia; MLL1; MLL cleavage product C180; Lysine N-methyltransferase 2A; Lysine Nmethyltransferase 2A; HTRX; HRX; Histonelysine Nmethyltransferase MLL; Histone-lysine N-methyltransferase 2A; CXXC-type zinc finger protein 7; CXXCtype zinc finger protein 7; CXXC7; ALL-1; ALL1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Reconstituted Complex | [1] | |||
4 | Reconstituted Complex | [2] | |||
Interacting Target Name | Enhancer of zeste homolog 2 (EZH2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Lysine N-methyltransferase 6; Lysine Nmethyltransferase 6; KMT6; Histone-lysine N-methyltransferase EZH2; Histonelysine Nmethyltransferase EZH2; EZH2 Y641N mutations; EZH2 Y641F mutations; ENX-1; ENX1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [50] | |||
2 | Reconstituted Complex | [51] | |||
Oxidoreductases | [+] 1 Oxidoreductases | + | |||
Interacting Protein Name | L-lactate dehydrogenase B chain (LDHB) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HEL.S.281; LDH.B; LDH.H; LDHBD; TRG.5 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [15] | |||
2 | Affinity Capture-MS | [3] | |||
Peptidases | [+] 2 Peptidases | + | |||
Interacting Target Name | Presenilin 1 (PSEN1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | S182 protein; PSNL1; PS-1; PS1; Protein S182; Presenilin-1; AD3 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [52] | |||
2 | Affinity Capture-Western | [53] | |||
3 | Affinity Capture-Western | [54] | |||
4 | Affinity Capture-Western | [55] | |||
5 | Reconstituted Complex | [53] | |||
Interacting Protein Name | Probable ubiquitin carboxyl-terminal hydrolase FAF-X (USP9X) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DFFRX; FAF; FAM; MRX99 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [56] | |||
2 | Affinity Capture-Western | [57] | |||
3 | Reconstituted Complex | [58] | |||
Ribosomal proteins | [+] 2 Ribosomal proteins | + | |||
Interacting Target Name | Laminin receptor 37/67kDa (LRP/LR) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Small ribosomal subunit protein uS2; NEM/1CHD4; Multidrug resistance-associated protein MGr1-Ag; LBP/p40; LAMR1; LamR; Laminin-binding protein precursor p40; Laminin receptor 1; LAMBR; Colon carcinoma laminin-binding protein; 67LR; 67 kDa laminin receptor; 40S ribosomal protein SA; 37LRP; 37/67 kDa laminin receptor; 37 kDa laminin receptor precursor | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [15] | |||
2 | Affinity Capture-MS | [3] | |||
Interacting Protein Name | Large ribosomal subunit protein P2 (RPLP2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | D11S2243E; LP2; P2; RPP2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [15] | |||
2 | Affinity Capture-MS | [3] | |||
Transcription regulators | [+] 10 Transcription regulators | + | |||
Interacting Protein Name | Transcription factor 4 (TCF4) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | E2.2; ITF.2; ITF2; PTHS; SEF.2; SEF2; SEF2.1; SEF2.1A; SEF2.1B; SEF2.1D; TCF.4; bHLHb19 | ||||
Evidence Score (E-score) | 15 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [59] | |||
2 | Affinity Capture-Western | [60] | |||
3 | Affinity Capture-Western | [61] | |||
4 | Affinity Capture-Western | [62] | |||
5 | Affinity Capture-Western | [10] | |||
6 | Affinity Capture-Western | [63] | |||
7 | Affinity Capture-Western | [29] | |||
8 | Affinity Capture-Western | [64] | |||
9 | Affinity Capture-Western | [65] | |||
10 | Affinity Capture-Western | [66] | |||
11 | Reconstituted Complex | [67] | |||
12 | Reconstituted Complex | [10] | |||
13 | Reconstituted Complex | [68] | |||
14 | Reconstituted Complex | [69] | |||
15 | Yeast two hybrid | [70] | |||
Interacting Protein Name | Lymphoid enhancer-binding factor 1 (LEF1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | LEF.1; TCF10; TCF1ALPHA; TCF7L3 | ||||
Evidence Score (E-score) | 13 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [71] | |||
3 | Affinity Capture-Western | [72] | |||
4 | Affinity Capture-Western | [73] | |||
5 | Affinity Capture-Western | [29] | |||
6 | Affinity Capture-Western | [17] | |||
7 | Affinity Capture-Western | [18] | |||
8 | Affinity Capture-Western | [74] | |||
9 | Affinity Capture-Western | [75] | |||
10 | Co-localization | [76] | |||
11 | Reconstituted Complex | [77] | |||
12 | Reconstituted Complex | [78] | |||
13 | Yeast two hybrid | [79] | |||
Interacting Target Name | Transcription factor 7-like 2 (TCF7L2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TCF-4; TCF4; T-cell-specific transcription factor 4; T-cell transcription factor-4; T-cell factor 4; HTCF-4; HMG box transcription factor 4 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [80] | |||
3 | Affinity Capture-Western | [27] | |||
4 | Affinity Capture-Western | [7] | |||
5 | Affinity Capture-Western | [81] | |||
6 | Co-crystal Structure | [82] | |||
7 | Co-localization | [83] | |||
8 | Reconstituted Complex | [84] | |||
Interacting Target Name | Transcription factor Sp1 (SP1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TSFP1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [28] | |||
2 | Affinity Capture-Western | [61] | |||
3 | Reconstituted Complex | [28] | |||
Interacting Target Name | DNA-binding factor KBF1 (p105) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; Nuclear factor of kappa light polypeptide gene enhancer in Bcells 1; Nuclear factor NFkappaB p50 subunit; Nuclear factor NF-kappa-B p105 subunit; Nuclear factor NFkappaB p105 subunit; EBP-1; EBP1; DNA-binding factor KBF1; DNAbinding factor KBF1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [8] | |||
2 | Co-localization | [8] | |||
Interacting Target Name | Mothers against decapentaplegic homolog 7 (SMAD7) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Smad7; SMAD family member 7; SMAD 7; Mothers against DPP homolog 8; Mothers against decapentaplegic homolog 8; MAD homolog 8; hSMAD7 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [71] | |||
2 | Co-localization | [71] | |||
Interacting Target Name | Transcription factor SOX-2 (SOX2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ANOP3; MCOPS3; SRY-box 2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [85] | |||
2 | Affinity Capture-Western | [86] | |||
Interacting Protein Name | Transcription factor BTF3 (BTF3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BETA.NAC; BTF3a; BTF3b; NACB | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [15] | |||
2 | Affinity Capture-MS | [3] | |||
Interacting Protein Name | Mothers against decapentaplegic homolog 2 (SMAD2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | JV18; JV18.1; MADH2; MADR2; hMAD.2; hSMAD2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [87] | |||
Interacting Protein Name | Transcription factor 7-like 1 (TCF7L1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TCF.3; TCF3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Co-crystal Structure | [88] | |||
2 | Protein-peptide | [89] | |||
Other proteins | [+] 29 Other proteins | + | |||
Interacting Target Name | Epithelial cadherin (CDH1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Uvomorulin; UVO; E-cadherin gene; E-cadherin; CDHE; CD324; CAM 120/80; Cadherin-1 | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [90] | |||
3 | Affinity Capture-Western | [91] | |||
4 | Affinity Capture-Western | [92] | |||
5 | Affinity Capture-Western | [93] | |||
6 | Affinity Capture-Western | [94] | |||
7 | Affinity Capture-Western | [95] | |||
8 | Affinity Capture-Western | [61] | |||
9 | Affinity Capture-Western | [40] | |||
10 | Affinity Capture-Western | [96] | |||
11 | Affinity Capture-Western | [97] | |||
12 | Affinity Capture-Western | [98] | |||
13 | Affinity Capture-Western | [99] | |||
14 | Affinity Capture-Western | [100] | |||
15 | Affinity Capture-Western | [101] | |||
16 | Affinity Capture-Western | [102] | |||
17 | Affinity Capture-Western | [63] | |||
18 | Co-crystal Structure | [103] | |||
19 | Co-localization | [61] | |||
20 | Fluorescence Resonance Energy Transfer | [104] | |||
Interacting Protein Name | F-box/WD repeat-containing protein 1A (BTRC) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BETA.TRCP; FBW1A; FBXW1; FBXW1A; FWD1; bTrCP; bTrCP1; betaTrCP | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [105] | |||
2 | Affinity Capture-Western | [106] | |||
3 | Affinity Capture-Western | [107] | |||
4 | Affinity Capture-Western | [28] | |||
5 | Affinity Capture-Western | [108] | |||
6 | Affinity Capture-Western | [109] | |||
7 | Affinity Capture-Western | [16] | |||
8 | Affinity Capture-Western | [110] | |||
9 | Affinity Capture-Western | [111] | |||
10 | Affinity Capture-Western | [112] | |||
11 | Affinity Capture-Western | [113] | |||
12 | Affinity Capture-Western | [114] | |||
13 | Affinity Capture-Western | [115] | |||
14 | Affinity Capture-Western | [116] | |||
15 | Protein-Fragment Complementation Assay | [117] | |||
16 | Protein-Fragment Complementation Assay | [118] | |||
17 | Protein-peptide | [119] | |||
18 | Reconstituted Complex | [106] | |||
19 | Reconstituted Complex | [120] | |||
20 | Reconstituted Complex | [121] | |||
Interacting Protein Name | Adenomatous polyposis coli protein (APC) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BTPS2; DP2; DP2.5; DP3; GS; PPP1R46 | ||||
Evidence Score (E-score) | 13 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [41] | |||
2 | Affinity Capture-MS | [3] | |||
3 | Affinity Capture-Western | [90] | |||
4 | Affinity Capture-Western | [25] | |||
5 | Affinity Capture-Western | [122] | |||
6 | Affinity Capture-Western | [26] | |||
7 | Affinity Capture-Western | [27] | |||
8 | Co-crystal Structure | [123] | |||
9 | Co-crystal Structure | [89] | |||
10 | Protein-peptide | [89] | |||
11 | Reconstituted Complex | [124] | |||
12 | Reconstituted Complex | [123] | |||
13 | Reconstituted Complex | [89] | |||
Interacting Protein Name | Axin-1 (AXIN1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AXIN; PPP1R49 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [125] | |||
2 | Affinity Capture-Western | [27] | |||
3 | Affinity Capture-Western | [106] | |||
4 | Affinity Capture-Western | [107] | |||
5 | Affinity Capture-Western | [28] | |||
6 | Reconstituted Complex | [125] | |||
7 | Reconstituted Complex | [106] | |||
8 | Yeast two hybrid | [125] | |||
Interacting Protein Name | Catenin alpha-1 (CTNNA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CAP102 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [15] | |||
2 | Affinity Capture-MS | [3] | |||
3 | Affinity Capture-MS | [41] | |||
4 | Affinity Capture-MS | [59] | |||
5 | Affinity Capture-Western | [96] | |||
6 | Affinity Capture-Western | [40] | |||
7 | Reconstituted Complex | [126] | |||
Interacting Target Name | Junction plakoglobin (JUP) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Plakoglobin; DP3; Desmoplakin-3; Desmoplakin III; CTNNG; Catenin gamma | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [41] | |||
2 | Affinity Capture-MS | [3] | |||
3 | Affinity Capture-Western | [90] | |||
4 | Affinity Capture-Western | [38] | |||
5 | Co-localization | [33] | |||
Interacting Target Name | Mucin-1 (MUC1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumour-associated antigen mucin 1; Tumor-associated mucin; Tumor-associated epithelial membraneantigen; Tumor-associated epithelial membrane antigen; PUM; Polymorphic epithelial mucin; PEMT; PEM; Peanut-reactive urinary mucin; Mucin-1; MUC-1; Krebs von den Lungen-6; KL-6; H23AG; Episialin; EMA; CD227 antigen; CD227; Carcinoma-associated mucin; Cancer antigen 15-3; CA 15-3; Breast carcinoma-associated antigen DF3 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [127] | |||
2 | Affinity Capture-Western | [128] | |||
3 | Reconstituted Complex | [128] | |||
4 | Reconstituted Complex | [129] | |||
Interacting Protein Name | S-phase kinase-associated protein 1 (SKP1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | EMC19; OCP.II; OCP2; SKP1A; TCEB1L; p19A | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [130] | |||
3 | Affinity Capture-Western | [111] | |||
4 | Protein-peptide | [119] | |||
Interacting Target Name | Placental cadherin (CDH3) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P-cadherin; Pcadherin; CDHP; Cadherin-3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [100] | |||
3 | Co-purification | [131] | |||
Interacting Target Name | Adenomatous polyposis coli 2 (APC2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | APC-like; APClike; APCL; Adenomatous polyposis coli protein-like; Adenomatous polyposis coli proteinlike; Adenomatous polyposis coli protein 2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [132] | |||
2 | Reconstituted Complex | [2] | |||
3 | Yeast two hybrid | [120] | |||
Interacting Protein Name | Beta-catenin-interacting protein 1 (CTNNBIP1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ICAT | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [59] | |||
2 | Affinity Capture-MS | [3] | |||
3 | Affinity Capture-Western | [24] | |||
Interacting Protein Name | Catenin delta-1 (CTNND1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CAS; CTNND; P120CAS; P120CTN; p120; p120(CAS); p120(CTN) | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [90] | |||
3 | Affinity Capture-Western | [38] | |||
Interacting Protein Name | Emerin (EMD) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | EDMD; LEMD5; STA | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [133] | |||
3 | Reconstituted Complex | [133] | |||
Interacting Protein Name | Four and a half LIM domains protein 2 (FHL2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AAG11; DRAL; FHL.2; SLIM.3; SLIM3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Reconstituted Complex | [134] | |||
3 | Yeast two hybrid | [134] | |||
Interacting Protein Name | Non-POU domain-containing octamer-binding protein (NONO) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NMT55; NRB54; P54; P54NRB; PPP1R114 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [3] | |||
3 | Affinity Capture-Western | [7] | |||
Interacting Protein Name | Retinoblastoma-binding protein 5 (RBBP5) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RBQ3; SWD1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [13] | |||
2 | Reconstituted Complex | [1] | |||
3 | Reconstituted Complex | [2] | |||
Interacting Protein Name | Heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Single-strand RNA-binding protein; HNRPA1; hnRNP core protein A1; hnRNP A1; Heterogeneous nuclear ribonucleoprotein A1; Helix-destabilizing protein | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [15] | |||
2 | Affinity Capture-MS | [3] | |||
3 | Affinity Capture-Western | [7] | |||
Interacting Protein Name | Heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HNRPA2B1; hnRNP A2/B1; Heterogeneous nuclear ribonucleoproteins A2/B1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [3] | |||
3 | Affinity Capture-Western | [7] | |||
Interacting Protein Name | Vinculin (VCL) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CMD1W; CMH15; HEL114; MV; MVCL | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [135] | |||
3 | Affinity Capture-Western | [136] | |||
Interacting Target Name | Poly [ADP-ribose] polymerase 1 (PARP1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein poly-ADP-ribosyltransferase PARP1; PPOL; Poly[ADP-ribose] synthetase-1; Poly[ADP-ribose] synthase 1; Poly(ADP-ribose)polymerase-1; PARP-1; NAD(+)Poly [ADP-ribose] polymerase-1 ADP-ribosyltransferase-1; NAD(+) ADP-ribosyltransferase-1; NAD(+) ADP-ribosyltransferase 1; DNA ADP-ribosyltransferase PARP1; ARTD1; ADPRT 1; ADPRT; ADP-ribosyltransferase diphtheria toxin-like 1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [3] | |||
Interacting Target Name | Neural cadherin (CDH2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | N-cadherin; NCAD; CDw325; CDHN; CD325; Cadherin-2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [137] | |||
2 | Affinity Capture-Western | [138] | |||
Interacting Target Name | Vascular endothelial cadherin (CDH5) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | VE-cadherin; VE-cad; CD144 antigen; CD144; Cadherin-5; 7B4 antigen | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [139] | |||
2 | Affinity Capture-Western | [140] | |||
Interacting Target Name | ELAV-like protein 1 (ELAVL1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HuR; Hu-antigen R | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Reconstituted Complex | [141] | |||
Interacting Target Name | Platelet endothelial cell adhesion molecule (PECAM1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PECAM-1; PECA1; GPIIA'; EndoCAM; ECAM; CD31 antigen; CD31 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [142] | |||
2 | Co-localization | [33] | |||
Interacting Protein Name | Cadherin-10 (CDH10) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [41] | |||
2 | Affinity Capture-Western | [143] | |||
Interacting Protein Name | Heterogeneous nuclear ribonucleoprotein K (HNRNPK) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CSBP; HNRPK; TUNP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [7] | |||
Interacting Protein Name | Heterogeneous nuclear ribonucleoprotein M (HNRNPM) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CEAR; HNRNPM4; HNRPM; HNRPM4; HTGR1; NAGR1; hnRNP M | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [3] | |||
Interacting Protein Name | Plasminogen activator inhibitor 1 RNA-binding protein (SERBP1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CHD3IP; HABP4L; PAI.RBP1; PAIRBP1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [15] | |||
2 | Affinity Capture-MS | [3] | |||
Interacting Protein Name | Pre-mRNA-processing factor 6 (PRPF6) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ANT.1; ANT1; C20orf14; Prp6; RP60; SNRNP102; TOM; U5.102K; hPrp6 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [3] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev. 2006 Mar 1;20(5):586-600. | ||||
REF 2 | Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Genes Dev. 2006 Mar 1;20(5):601-12. | ||||
REF 3 | Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in -Catenin-Active Cancers. Cell Syst. 2016 Sep 28;3(3):302-316.e4. | ||||
REF 4 | Pontin52, an interaction partner of beta-catenin, binds to the TATA box binding protein. Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14787-92. | ||||
REF 5 | CHD8 is an ATP-dependent chromatin remodeling factor that regulates beta-catenin target genes. Mol Cell Biol. 2008 Jun;28(12):3894-904. | ||||
REF 6 | Histone H1 recruitment by CHD8 is essential for suppression of the Wnt--catenin signaling pathway. Mol Cell Biol. 2012 Jan;32(2):501-12. | ||||
REF 7 | Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. Gastroenterology. 2005 Oct;129(4):1225-36. | ||||
REF 8 | Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature. 2005 Apr 14;434(7035):921-6. | ||||
REF 9 | Regulation of beta -catenin transformation by the p300 transcriptional coactivator. Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12613-8. | ||||
REF 10 | Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction. Mol Cell Biol. 2004 Apr;24(8):3404-14. | ||||
REF 11 | c-Cbl, a ubiquitin E3 ligase that targets active -catenin: a novel layer of Wnt signaling regulation. J Biol Chem. 2013 Aug 9;288(32):23505-17. | ||||
REF 12 | E3 ubiquitin ligase Mule targets -catenin under conditions of hyperactive Wnt signaling. Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):E1148-E1157. | ||||
REF 13 | Pygo2 associates with MLL2 histone methyltransferase and GCN5 histone acetyltransferase complexes to augment Wnt target gene expression and breast cancer stem-like cell expansion. Mol Cell Biol. 2010 Dec;30(24):5621-35. | ||||
REF 14 | Specific armadillo repeat sequences facilitate -catenin nuclear transport in live cells via direct binding to nucleoporins Nup62, Nup153, and RanBP2/Nup358. J Biol Chem. 2012 Jan 6;287(2):819-31. | ||||
REF 15 | Proteomic analysis identifies that 14-3-3zeta interacts with beta-catenin and facilitates its activation by Akt. Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15370-5. | ||||
REF 16 | A novel function of YWHAZ/-catenin axis in promoting epithelial-mesenchymal transition and lung cancer metastasis. Mol Cancer Res. 2012 Oct;10(10):1319-31. | ||||
REF 17 | TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent. J Biol Chem. 2005 Dec 2;280(48):39795-801. | ||||
REF 18 | Beta-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator. Mol Cell Biol. 2000 Sep;20(18):6882-90. | ||||
REF 19 | SOX6 suppresses cyclin D1 promoter activity by interacting with beta-catenin and histone deacetylase 1, and its down-regulation induces pancreatic beta-cell proliferation. J Biol Chem. 2007 Jun 29;282(26):19052-61. | ||||
REF 20 | Histone deacetylase 7 controls endothelial cell growth through modulation of beta-catenin. Circ Res. 2010 Apr 16;106(7):1202-11. | ||||
REF 21 | Splicing of histone deacetylase 7 modulates smooth muscle cell proliferation and neointima formation through nuclear -catenin translocation. Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2676-84. | ||||
REF 22 | The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF-beta-catenin-mediated transcription. J Cell Sci. 2005 Jul 15;118(Pt 14):3117-29. | ||||
REF 23 | The tumor suppressor HINT1 regulates MITF and -catenin transcriptional activity in melanoma cells. Cell Cycle. 2012 Jun 1;11(11):2206-15. | ||||
REF 24 | Wnt-induced deubiquitination FoxM1 ensures nucleus -catenin transactivation. EMBO J. 2016 Mar 15;35(6):668-84. | ||||
REF 25 | The interaction between beta-catenin, GSK3beta and APC after motogen induced cell-cell dissociation, and their involvement in signal transduction p... Int J Oncol. 2001 Apr;18(4):843-7. | ||||
REF 26 | The COP9 signalosome mediates beta-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15. J Mol Biol. 2009 Aug 28;391(4):691-702. | ||||
REF 27 | Ubiquitin ligase E6AP mediates nonproteolytic polyubiquitylation of -catenin independent of the E6 oncoprotein. J Gen Virol. 2016 Dec;97(12):3313-3330. | ||||
REF 28 | Regulation of Transcription Factor SP1 by the -Catenin Destruction Complex Modulates Wnt Response. Mol Cell Biol. 2018 Oct 29;38(22). pii: e00188-18. | ||||
REF 29 | Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/-catenin signaling axis. Oncogene. 2012 Feb 16;31(7):842-57. | ||||
REF 30 | USP7 Is a Tumor-Specific WNT Activator for APC-Mutated Colorectal Cancer by Mediating -Catenin Deubiquitination. Cell Rep. 2017 Oct 17;21(3):612-627. | ||||
REF 31 | NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3 and Nur77 to prevent -catenin degradation. Oncotarget. 2015 Oct 6;6(30):29847-59. | ||||
REF 32 | DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability. Mol Cell Biol. 1999 Jun;19(6):4414-22. | ||||
REF 33 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 34 | ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas. J Biol Chem. 2002 Jun 21;277(25):22692-8. | ||||
REF 35 | c-erbB-2 gene product directly associates with beta-catenin and plakoglobin. Biochem Biophys Res Commun. 1995 Mar 28;208(3):1067-72. | ||||
REF 36 | Cell-type-specific function of BCL9 involves a transcriptional activation domain that synergizes with beta-catenin. Mol Cell Biol. 2008 May;28(10):3526-37. | ||||
REF 37 | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. Mol Syst Biol. 2013 Nov 5;9:705. | ||||
REF 38 | The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton. J Biol Chem. 1998 Apr 10;273(15):9078-84. | ||||
REF 39 | Cadherin-11 interacts with the FGF receptor and induces neurite outgrowth through associated downstream signalling. Cell Signal. 2008 Jun;20(6):1061-72. | ||||
REF 40 | p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction. Mol Cell Biol. 2003 Apr;23(7):2287-97. | ||||
REF 41 | A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell. 2015 Oct 22;163(3):712-23. | ||||
REF 42 | Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation. J Biol Chem. 2015 May 29;290(22):14120-9. | ||||
REF 43 | PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis. Nat Commun. 2016 Aug 3;7:12431. | ||||
REF 44 | LATS2 suppresses oncogenic Wnt signaling by disrupting -catenin/BCL9 interaction. Cell Rep. 2013 Dec 26;5(6):1650-63. | ||||
REF 45 | Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions. Sci Signal. 2013 Nov 19;6(302):rs15. | ||||
REF 46 | Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis. Oncogene. 2003 Aug 28;22(36):5602-13. | ||||
REF 47 | Coordinated action of hypoxia-inducible factor-1 and -catenin in androgen receptor signaling. J Biol Chem. 2012 Sep 28;287(40):33594-606. | ||||
REF 48 | Linking beta-catenin to androgen-signaling pathway. J Biol Chem. 2002 Mar 29;277(13):11336-44. | ||||
REF 49 | Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway. J Biol Chem. 2003 Aug 8;278(32):29954-62. | ||||
REF 50 | Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia. Am J Pathol. 2009 Sep;175(3):1246-54. | ||||
REF 51 | Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol Cell Biol. 2007 Jul;27(14):5105-19. | ||||
REF 52 | Direct association of presenilin-1 with beta-catenin. FEBS Lett. 1998 Aug 14;433(1-2):73-7. | ||||
REF 53 | A structural switch of presenilin 1 by glycogen synthase kinase 3beta-mediated phosphorylation regulates the interaction with beta-catenin and its nuclear signaling. J Biol Chem. 2007 May 11;282(19):14083-93. | ||||
REF 54 | Cadherins mediate both the association between PS1 and beta-catenin and the effects of PS1 on beta-catenin stability. J Biol Chem. 2005 Oct 28;280(43):36007-12. | ||||
REF 55 | Presenilin-1 interacts with plakoglobin and enhances plakoglobin-Tcf-4 association. Implications for the regulation of beta-catenin/Tcf-4-dependent transcription. J Biol Chem. 2006 Jan 20;281(3):1401-11. | ||||
REF 56 | Deubiquitinase USP9X deubiquitinates -catenin and promotes high grade glioma cell growth. Oncotarget. 2016 Nov 29;7(48):79515-79525. | ||||
REF 57 | -catenin is regulated by USP9x and mediates resistance to TRAIL-induced apoptosis in breast cancer. Oncol Rep. 2016 Feb;35(2):717-24. | ||||
REF 58 | The deubiquitinating enzyme Fam interacts with and stabilizes beta-catenin. Genes Cells. 1999 Dec;4(12):757-67. | ||||
REF 59 | Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK). Nat Methods. 2006 Dec;3(12):981-3. | ||||
REF 60 | The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF. Dev Cell. 2004 Nov;7(5):677-85. | ||||
REF 61 | Acute and chronic cadmium exposure promotes E-cadherin degradation in MCF7 breast cancer cells. Mol Carcinog. 2015 Oct;54(10):1014-25. | ||||
REF 62 | Tumor necrosis factor -induced hypoxia-inducible factor 1--catenin axis regulates major histocompatibility complex class I gene activation through chromatin remodeling. Mol Cell Biol. 2013 Jul;33(14):2718-31. | ||||
REF 63 | beta-catenin regulates multiple steps of RNA metabolism as revealed by the RNA aptamer in colon cancer cells. Cancer Res. 2007 Oct 1;67(19):9315-21. | ||||
REF 64 | Ring Finger Protein 14 is a new regulator of TCF/-catenin-mediated transcription and colon cancer cell survival. EMBO Rep. 2013 Apr;14(4):347-55. | ||||
REF 65 | Sumoylation is involved in beta-catenin-dependent activation of Tcf-4. EMBO J. 2003 May 1;22(9):2047-59. | ||||
REF 66 | Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility. Carcinogenesis. 2014 Aug;35(8):1901-10. | ||||
REF 67 | Hot spots in Tcf4 for the interaction with beta-catenin. J Biol Chem. 2003 Jun 6;278(23):21092-8. | ||||
REF 68 | Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner. PLoS Biol. 2010 Jan 26;8(1):e1000296. | ||||
REF 69 | In silico prediction of physical protein interactions and characterization of interactome orphans. Nat Methods. 2015 Jan;12(1):79-84. | ||||
REF 70 | -catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19204-9. | ||||
REF 71 | Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis. Mol Cell Biol. 2005 Feb;25(4):1475-88. | ||||
REF 72 | Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. J Cell Biochem. 2002;84(4):816-31. | ||||
REF 73 | Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells. J Cell Sci. 2002 Jul 1;115(Pt 13):2771-80. | ||||
REF 74 | A functional screen in human cells identifies UBF2 as an RNA polymerase II transcription factor that enhances the beta-catenin signaling pathway. Mol Cell Biol. 2003 Jun;23(11):3936-50. | ||||
REF 75 | Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin. Oncogene. 1997 Dec 4;15(23):2833-9. | ||||
REF 76 | Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro. Genes Dev. 2001 Dec 15;15(24):3342-54. | ||||
REF 77 | Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat Struct Mol Biol. 2005 Apr;12(4):364-71. | ||||
REF 78 | PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. J Cell Sci. 2005 Mar 15;118(Pt 6):1129-37. | ||||
REF 79 | Functional interaction of beta-catenin with the transcription factor LEF-1. Nature. 1996 Aug 15;382(6592):638-42. | ||||
REF 80 | Wnt controls the transcriptional activity of Kaiso through CK1-dependent phosphorylation of p120-catenin. J Cell Sci. 2011 Jul 1;124(Pt 13):2298-309. | ||||
REF 81 | -catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells. Gastroenterology. 2012 Mar;142(3):572-81. | ||||
REF 82 | Tcf4 can specifically recognize beta-catenin using alternative conformations. Nat Struct Biol. 2001 Dec;8(12):1048-52. | ||||
REF 83 | HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells. Endocr Relat Cancer. 2007 Sep;14(3):655-67. | ||||
REF 84 | Physiological and functional interactions between Tcf4 and Daxx in colon cancer cells. J Biol Chem. 2006 Jun 2;281(22):15405-11. | ||||
REF 85 | The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells. PLoS One. 2013 May 7;8(5):e62857. | ||||
REF 86 | -Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma. Cancer Res. 2013 May 15;73(10):3181-9. | ||||
REF 87 | Identification of pY654--catenin as a critical co-factor in hypoxia-inducible factor-1 signaling and tumor responses to hypoxia. Oncogene. 2013 Oct 17;32(42):5048-57. | ||||
REF 88 | Crystal structure of a beta-catenin/Tcf complex. Cell. 2000 Dec 8;103(6):885-96. | ||||
REF 89 | Crystal structure of a beta-catenin/APC complex reveals a critical role for APC phosphorylation in APC function. Mol Cell. 2004 Aug 27;15(4):523-33. | ||||
REF 90 | Expression and interaction of different catenins in colorectal carcinoma cells. Int J Mol Med. 2001 Dec;8(6):695-8. | ||||
REF 91 | MAGI-1 interacts with beta-catenin and is associated with cell-cell adhesion structures. Biochem Biophys Res Commun. 2000 Apr 21;270(3):903-9. | ||||
REF 92 | Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. Biochem J. 2002 Dec 1;368(Pt 2):471-81. | ||||
REF 93 | Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells. Mol Cell Proteomics. 2007 Apr;6(4):575-88. | ||||
REF 94 | Human NRAGE disrupts E-cadherin/beta-catenin regulated homotypic cell-cell adhesion. Biochem Biophys Res Commun. 2005 Oct 14;336(1):247-51. | ||||
REF 95 | Protein-tyrosine phosphatase PCP-2 inhibits beta-catenin signaling and increases E-cadherin-dependent cell adhesion. J Biol Chem. 2006 Jun 2;281(22):15423-33. | ||||
REF 96 | A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res. 1994 Dec 1;54(23):6282-7. | ||||
REF 97 | Ksp-cadherin is a functional cell-cell adhesion molecule related to LI-cadherin. Exp Cell Res. 2004 Apr 1;294(2):345-55. | ||||
REF 98 | EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Hepatology. 2003 Jul;38(1):178-86. | ||||
REF 99 | Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation. Biochim Biophys Acta. 2000 Dec 15;1535(1):21-35. | ||||
REF 100 | The fate of E- and P-cadherin during the early stages of apoptosis. Cell Death Differ. 1999 Apr;6(4):377-86. | ||||
REF 101 | Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling. Cancer Res. 2008 Jul 1;68(13):5086-95. | ||||
REF 102 | Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties. Oncogene. 2012 Aug 9;31(32):3709-20. | ||||
REF 103 | The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell. 2001 May 4;105(3):391-402. | ||||
REF 104 | The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC. Eur J Hum Genet. 2013 Mar;21(3):301-9. | ||||
REF 105 | Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells. J Biol Chem. 2006 Jun 30;281(26):17751-7. | ||||
REF 106 | An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J. 1999 May 4;18(9):2401-10. | ||||
REF 107 | Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease. EMBO J. 2010 Jul 21;29(14):2433-45. | ||||
REF 108 | S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science. 2006 Oct 20;314(5798):467-71. | ||||
REF 109 | Control of chromosome stability by the beta-TrCP-REST-Mad2 axis. Nature. 2008 Mar 20;452(7185):365-9. | ||||
REF 110 | betaTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosis. Mol Cell. 2009 Jan 16;33(1):109-16. | ||||
REF 111 | Hypoxia-induced -catenin downregulation involves p53-dependent activation of Siah-1. Cancer Sci. 2011 Jul;102(7):1322-8. | ||||
REF 112 | Wnt signaling through inhibition of -catenin degradation in an intact Axin1 complex. Cell. 2012 Jun 8;149(6):1245-56. | ||||
REF 113 | Nek2 phosphorylates and stabilizes -catenin at mitotic centrosomes downstream of Plk1. Mol Biol Cell. 2014 Apr;25(7):977-91. | ||||
REF 114 | Induction of Gsk3--TrCP interaction is required for late phase stabilization of -catenin in canonical Wnt signaling. J Biol Chem. 2014 Mar 7;289(10):7099-108. | ||||
REF 115 | Growth-arrest-specific 7C protein inhibits tumor metastasis via the N-WASP/FAK/F-actin and hnRNP U/-TrCP/-catenin pathways in lung cancer. Oncotarget. 2015 Dec 29;6(42):44207-21. | ||||
REF 116 | Inactivation of ABL kinases suppresses non-small cell lung cancer metastasis. JCI Insight. 2016 Dec 22;1(21):e89647. | ||||
REF 117 | The transmembrane domain of HIV-1 Vpu is sufficient to confer anti-tetherin activity to SIVcpz and SIVgor Vpu proteins: cytoplasmic determinants of Vpu function. Retrovirology. 2013 Mar 20;10:32. | ||||
REF 118 | Dual-color click beetle luciferase heteroprotein fragment complementation assays. Chem Biol. 2010 Sep 24;17(9):1018-29. | ||||
REF 119 | The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev. 1999 Feb 1;13(3):270-83. | ||||
REF 120 | The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol. 1999 Feb 25;9(4):207-10. | ||||
REF 121 | Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation. Mol Cell. 2008 Oct 10;32(1):21-31. | ||||
REF 122 | Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol. 2001 Sep;3(9):793-801. | ||||
REF 123 | Molecular mechanisms of beta-catenin recognition by adenomatous polyposis coli revealed by the structure of an APC-beta-catenin complex. EMBO J. 2001 Nov 15;20(22):6203-12. | ||||
REF 124 | Differences between the interaction of beta-catenin with non-phosphorylated and single-mimicked phosphorylated 20-amino acid residue repeats of the APC protein. J Mol Biol. 2003 Mar 21;327(2):359-67. | ||||
REF 125 | Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level. Genes Cells. 1998 Jun;3(6):395-403. | ||||
REF 126 | EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin. Mol Cell. 2009 Nov 25;36(4):547-59. | ||||
REF 127 | MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion. Oncogene. 2003 Mar 6;22(9):1324-32. | ||||
REF 128 | The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin. J Biol Chem. 2001 Mar 2;276(9):6061-4. | ||||
REF 129 | The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. J Biol Chem. 2001 Sep 21;276(38):35239-42. | ||||
REF 130 | Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell. 2001 May;7(5):915-26. | ||||
REF 131 | Amino-terminal domain of classic cadherins determines the specificity of the adhesive interactions. J Cell Sci. 2000 Aug;113 ( Pt 16):2829-36. | ||||
REF 132 | Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation. PLoS One. 2013 Jul 1;8(7):e68072. | ||||
REF 133 | The inner nuclear membrane protein emerin regulates beta-catenin activity by restricting its accumulation in the nucleus. EMBO J. 2006 Jul 26;25(14):3275-85. | ||||
REF 134 | Identification of the LIM protein FHL2 as a coactivator of beta-catenin. J Biol Chem. 2003 Feb 14;278(7):5188-94. | ||||
REF 135 | Mediating effects of aryl-hydrocarbon receptor and RhoA in altering brain vascular integrity: the therapeutic potential of statins. Am J Pathol. 2012 Jul;181(1):211-21. | ||||
REF 136 | Vinculin is associated with the E-cadherin adhesion complex. J Biol Chem. 1997 Dec 19;272(51):32448-53. | ||||
REF 137 | A novel cell-cell junction system: the cortex adhaerens mosaic of lens fiber cells. J Cell Sci. 2003 Dec 15;116(Pt 24):4985-95. | ||||
REF 138 | N-cadherin-catenin complexes form prior to cleavage of the proregion and transport to the plasma membrane. J Biol Chem. 2003 May 9;278(19):17269-76. | ||||
REF 139 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 140 | Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro. Exp Cell Res. 1997 Dec 15;237(2):347-56. | ||||
REF 141 | -Catenin recognizes a specific RNA motif in the cyclooxygenase-2 mRNA 3'-UTR and interacts with HuR in colon cancer cells. Nucleic Acids Res. 2012 Aug;40(14):6863-72. | ||||
REF 142 | Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation. J Biol Chem. 2000 Jul 14;275(28):21435-43. | ||||
REF 143 | Identification of three human type-II classic cadherins and frequent heterophilic interactions between different subclasses of type-II classic cadherins. Biochem J. 2000 Jul 1;349(Pt 1):159-67. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.